CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia.
Jiang YP, Liu BY, Zheng Q, Panuganti S, Chen R, Zhu J, Mishra M, Huang J, Dao-Pick T, Roy S, Zhao X, Lin J, Banik G, Hsi ED, Mandalam R, Junutula JR.
Jiang YP, et al. Among authors: chen r.
Blood Adv. 2018 Jul 24;2(14):1738-1749. doi: 10.1182/bloodadvances.2018020107.
Blood Adv. 2018.
PMID: 30037800
Free PMC article.